Bryan Ronain Smith - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Bryan Ronain Smith

Showing results (31-40 of 33) with videos related to

Pageof 4

Sort By:

You have reached the last page of results.This site can display upto 33 results.

Nature Nanotechnology|January 29, 2020

Pro-efferocytic nanoparticles are specifically taken up by lesional macrophages and prevent atherosclerosisAlyssa M Flores, Niloufar Hosseini-Nassab, Kai-Uwe Jarr, et al.

International Journal of Pharmaceutics|November 15, 2025

PLGA-integrated micro/nanoparticles for cargo delivery and nanomedicine of lung cancerSareh Kakavandi, Iman Zare, Narges Esmaeilnejad, et al.

Nature Communications|September 13, 2024

Pro-efferocytic nanotherapies reduce vascular inflammation without inducing anemia in a large animal model of atherosclerosisSharika Bamezai, Yapei Zhang, Manisha Kumari, et al.

Pageof 4

Search research articles

Showing results (31-40 of 33) with videos related to

Sort By:

Pageof 4

You have reached the last page of results.This site can display upto 33 results.

Nature Nanotechnology|January 29, 2020

Pro-efferocytic nanoparticles are specifically taken up by lesional macrophages and prevent atherosclerosisAlyssa M Flores, Niloufar Hosseini-Nassab, Kai-Uwe Jarr, et al.

International Journal of Pharmaceutics|November 15, 2025

PLGA-integrated micro/nanoparticles for cargo delivery and nanomedicine of lung cancerSareh Kakavandi, Iman Zare, Narges Esmaeilnejad, et al.

Nature Communications|September 13, 2024

Pro-efferocytic nanotherapies reduce vascular inflammation without inducing anemia in a large animal model of atherosclerosisSharika Bamezai, Yapei Zhang, Manisha Kumari, et al.

Pageof 4